H₂‐antagonist maintenance therapy versus <i>Helicobacter pylori</i> eradication in patients with chronic duodenal ulcer disease: a prospective study

Abstract

Following successful H. pylori eradication, chronic duodenal ulcer patients were at least as well symptomatically as when taking maintenance ranitidine. They perceived that their health had improved, but a subgroup was still acid-suppression dependent.